PhenoTA utilizes advanced AI algorithms to analyze blood cell data from routine blood tests, providing detailed insights into individual health conditions. This technology enhances medical decision-making by delivering precise, actionable information that can lead to earlier diagnosis and improved patient outcomes.
Funding
Funding not disclosed
Founders
Product
Problem
Current diagnostic methods often fail to extract comprehensive insights from routine blood tests, potentially overlooking early indicators of disease or subtle changes in a patient's health status. Traditional analysis may not capture the full complexity of blood cell data, leading to delayed diagnoses or missed opportunities for preventative care.
Solution
PhenoTA employs advanced artificial intelligence algorithms to analyze blood cell data obtained from standard blood tests, providing clinicians with detailed and actionable insights into a patient's health. By applying AI to routine blood work, PhenoTA aims to enhance medical decision-making through more precise and comprehensive information. The technology identifies subtle patterns and anomalies in blood cell data that may be indicative of underlying health conditions, enabling earlier diagnosis and potentially improving patient outcomes. PhenoTA's analysis provides a more granular understanding of individual health, facilitating personalized treatment plans and proactive healthcare management.
Target Audience
PhenoTA's primary target audience includes healthcare providers, diagnostic laboratories, and medical researchers seeking to improve the accuracy and efficiency of disease detection and monitoring through advanced blood analysis.
Features
- AI-driven analysis of blood cell morphology and composition
- Identification of subtle biomarkers and patterns indicative of disease
- Generation of detailed reports with actionable insights for clinicians
- Integration with existing laboratory information systems (LIS)
- Longitudinal tracking of blood cell changes over time